Moreover, to explore the molecular mechanism in detail, we used a phospho-antibody array and screened more than 200 molecules clustered in twelve cancer-related pathways and found that total ERK3 exhibited the highest variation in ICC cells after treatment with metformin and ATO. The gene discussed is MAPK6; the disease is cancer.